Renflexis (infliximab-abda) is a medication used to treat various inflammatory conditions, including rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriasis, and psoriatic arthritis. Renflexis is a biosimilar to Remicade (infliximab) and works by reducing inflammation in the body.
Dosage and Administration:
Renflexis is administered through an intravenous (IV) infusion, which is typically given in a healthcare setting such as a hospital or clinic. The dosage and frequency of Renflexis treatment will vary depending on the patient's specific condition and individual response to treatment. It is important to follow the healthcare provider's instructions carefully when taking Renflexis.
Potential Side Effects:
As with any medication, there are potential side effects that may occur with Renflexis. The most common side effects reported with Renflexis include headache, nausea, fever, chills, fatigue, and respiratory infections. It is important to notify your healthcare provider if you experience any of these symptoms or if they worsen over time.
Rare but serious side effects associated with Renflexis may include infusion reactions, heart failure, liver problems, blood disorders, and nervous system disorders. Patients should notify their healthcare provider immediately if they experience any of these symptoms or other serious side effects.
Patients should not receive Renflexis if they have a known allergy to infliximab or any of its components. Patients with active infections should also not receive Renflexis as it may worsen the infection.
Patients should inform their healthcare provider of any pre-existing medical conditions, including liver disease, heart failure, blood disorders, or nervous system disorders. Patients who are pregnant or breastfeeding should also notify their healthcare provider before receiving Renflexis.
Renflexis may interact with other medications, including live vaccines and immunosuppressive agents. Patients should inform their healthcare provider of all medications and supplements they are taking before receiving Renflexis.
Renflexis should be stored at the recommended temperature and protected from light. Patients should never freeze Renflexis or use it after the expiration date.
Renflexis is an effective treatment option for various inflammatory conditions. Patients should follow their healthcare provider's instructions carefully and notify them of any side effects or pre-existing medical conditions. Patients should also inform their healthcare provider of all medications and supplements they are taking before receiving Renflexis. If you have any questions or concerns about Renflexis, please consult with your healthcare provider.